PERSISTENT DISEASE

Clinical trials for PERSISTENT DISEASE explained in plain language.

Never miss a new study

Get alerted when new PERSISTENT DISEASE trials appear

Sign up with your email to follow new studies for PERSISTENT DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Second chance: vyxeos targets tough leukemia after standard chemo fails

Disease control Recruiting now

This study tests a drug called Vyxeos in adults with acute myeloid leukemia (AML) whose cancer did not go away after standard chemotherapy. Vyxeos combines two chemo drugs inside a tiny fat bubble (liposome) to deliver them more effectively. The trial will check for side effects …

Matched conditions: PERSISTENT DISEASE

Phase: PHASE1, PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC

PERSISTENT DISEASE

Get alerted when new PERSISTENT DISEASE trials appear

Second chance: vyxeos targets tough leukemia after standard chemo fails